News tagged with hematology
Researchers discover master regulator that drives majority of lymphoma
A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell ...
Cancer
May 13, 2013 |
5 / 5 (3) |
0
|
Study identifies possible new acute leukemia marker, treatment target
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...
Cancer
May 13, 2013 |
not rated yet |
0
Leading leukemia experts: High leukemia treatment costs may be harming patients
The increasing cost of treatments for chronic myeloid leukemia (CML) in the United States has reached unsustainably high levels and may be leaving many patients under- or untreated because they cannot afford care, according ...
Cancer
Apr 25, 2013 |
not rated yet |
0
Key bone marrow protein identified as potential new leukemia treatment target
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be ...
Cancer
Apr 15, 2013 |
not rated yet |
0
Cancer patients may be unintended victims of budget cuts
(HealthDay)—Thousands of Medicare cancer patients are being denied treatment at clinics nationwide because of federal budget cuts related to the so-called sequester, according to a published report.
Health
Apr 04, 2013 |
5 / 5 (1) |
0
Researchers study use of dasatinib for patients with high-risk MDS
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, ...
Cancer
Mar 21, 2013 |
not rated yet |
0
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Risk of leukemia after cancer chemotherapy persists
While advancements in cancer treatment over the last several decades have improved patient survival rates for certain cancers, some patients remain at risk of developing treatment-related leukemia, according to results of ...
Cancer
Feb 14, 2013 |
5 / 5 (1) |
0
Breast cancer research needs more focus on environment: report
(HealthDay)—Efforts to prevent breast cancer need to focus more aggressively and coherently on environmental factors.
Cancer
Feb 12, 2013 |
not rated yet |
0
Spin and bias in published studies of breast cancer trials
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to new research published in the cancer journal Annals of ...
Cancer
Jan 09, 2013 |
not rated yet |
0
|
Survey shows breakthrough medical research relies heavily on NIH funding
A survey highlighting the correlation between today's cutting edge medical research and the National Institutes of Health (NIH) funding was released today at the 54th Annual Meeting of the American Society of Hematology (ASH), ...
Other
Dec 10, 2012 |
not rated yet |
0
New blood thinner may help prevent leg clots, study finds
(HealthDay)—The new anti-clotting drug apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.
Medications
Dec 10, 2012 |
5 / 5 (3) |
0
|
Reduced intensity regimen prior to marrow transplant better for older leukemia patients
A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows that preparing older acute myeloid ...
Cancer
Dec 10, 2012 |
not rated yet |
0
|
Engineered immune cells produce complete response in child with an aggressive pediatric leukemia
By reprogramming a 7-year-old girl's own immune cells to attack an aggressive form of childhood leukemia, a pediatric oncologist has achieved a complete response in his patient, who faced grim prospects when she relapsed ...
Cancer
Dec 09, 2012 |
5 / 5 (1) |
0
New stem cell research, transplant strategies show promise to improve outcomes, reduce complications
Studies of stem cell biology and transplant approaches presented today at the 54th Annual Meeting of the American Society of Hematology (ASH) illustrate how the use of advanced modeling techniques is optimizing stem cells ...
Medical research
Dec 09, 2012 |
not rated yet |
0
Hematology
Hematology, also spelled haematology, is the branch of biology (physiology), pathology, clinical laboratory, internal medicine, and pediatrics that is concerned with the study of blood, the blood-forming organs, and blood diseases. Hematology includes the study of etiology, diagnosis, treatment, prognosis, and prevention of blood diseases. The lab work that goes into the study of blood is performed by a medical technologist.
Blood diseases affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, the mechanism of coagulation, etc.
Physicians specialized in hematology are known as hematologists. Their routine work mainly includes the care and treatment of patients with hematological diseases, although some may also work at the haematology laboratory viewing blood films and bone marrow slides under the microscope, interpreting various haematological test results. In some institutions, haematologists also manage the haematology laboratory. Physicians who work in haematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of haematological diseases, referred to as haematopathologists. Haematologists and haematopathologists generally work in conjunction to formulate a diagnosis and deliver the most appropriate therapy if needed. Haematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. Haematologists may specialise further or have special interests, for example in:
only some blood disorders can be cured.
(Hematology comes from the Greek words ἁίμα (haima) meaning "blood" and λόγος (logos), a root commonly employed to denote a field of study.)
For more information about Hematology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.